Avanos Medical, Inc.AVNSNYSE
Loading
AVNS Revenue Growth (YoY Quarterly)•+0.72%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
+0.72%
-3.6pp
-13.39%
-0.7pp
+0.00%
+59.0pp
-814.40%
-792.8pp
+0.00%
+132.6pp
+0.00%
+132.3pp
+0.00%
+132.7pp
+0.87%
+0.0pp
+0.87%
+1.3pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +3.64% | +0.84% | +1.92% | +4.34% | +0.72% |
| Gross Profit Growth | +4.53% | -5.27% | -3.66% | -12.70% | -13.39% |
| EBITDA Growth | -1815.61% | +33.75% | -410.19% | -59.02% | +0.00% |
| Operating Income Growth | -43.69% | -1.35% | -54.66% | -21.56% | -814.40% |
| Net Income Growth | -3883.81% | +0.00% | -4366.67% | -132.56% | +0.00% |
| EPS Growth | -3856.52% | +0.00% | -4334.69% | -132.30% | +0.00% |
| EPS Diluted Growth | -3856.52% | +0.00% | -4334.69% | -132.72% | +0.00% |
| Weighted Average Shares Growth | -0.43% | -0.22% | +0.44% | +0.87% | +0.87% |
| Weighted Average Shares Diluted Growth | -1.29% | +1.30% | +1.08% | -0.43% | +0.87% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +355.91% | +0.00% | -75.54% | -39.13% | -51.30% |
| Free Cash Flow Growth | +680.88% | +0.00% | -119.18% | -65.00% | -59.89% |
| Receivables Growth | -7.00% | -20.18% | -10.41% | -15.62% | -21.84% |
| Inventory Growth | -14.95% | -16.61% | -12.93% | -6.98% | +6.63% |
| Asset Growth | -31.80% | -33.32% | -37.33% | -35.53% | -6.97% |
| Book Value per Share Growth | -32.69% | -31.49% | -36.75% | -37.28% | -6.88% |
| Debt Growth | -18.60% | -34.37% | -37.10% | -33.88% | -24.15% |
| R&D Expense Growth | -16.18% | -22.86% | -7.94% | -19.44% | +7.02% |
| SG&A Expenses Growth | +22.88% | -4.10% | +7.92% | -9.86% | -4.19% |
1 / 4